Antiplatelet bleeding safety — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Increased gastrointestinal bleeding risk
NSAIDs increase gastrointestinal bleeding risk, particularly with dual antiplatelet therapy. The pharmacist should advise a safer analgesic approach and refer if needed. In this scenario, the correct option is increased gastrointestinal bleeding risk. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.
Reference: BNF; Stockley's Drug Interactions